RNS Reach
4 June 2021
Oxford Cannabinoid Technologies Holdings plc
Company presentation webinar to retail investors
Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), a UK based pharmaceutical company focussed on developing cannabinoid-based prescription medicines approved by regulatory agencies, is pleased to announce that its CEO, Dr. John Lucas, and Executive Chairman, Neil Mahapatra, will conduct two live presentations to retail investors following its recent admission to trading on the Main Market of the London Stock Exchange.
The presentations will provide an opportunity for potential investors to learn about the Company and its outlook for the year ahead.
The live webinars, hosted by AJ Bell/Shares and Yellowstone Advisers, will take place on Tuesday 8th June 2021 at 19.45 and Thursday 10 June 2021 at 13.00, respectively.
The online presentations are open to all existing and potential investors and registration is free. Questions can be submitted during the presentation and will be addressed at the end.
To register, please go to:
- AJ Bell/Shares - https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-080621
- Yellowstone - https://www.yellowstoneadvisory.com/event-details/oxford-cannabinoid-technologies-plc-webinar
For more information please contact:
Oxford Cannabinoid Technologies Holdings plc - Dr John Lucas (CEO)
079 5687 3125 / john@oxcantech.com
PR Advisers: Acuitas Communications - James Gittings/Simon Nayyar
020 3848 2810 / james.gittings@acuitascomms.com